Early cerebral small vessel disease and brain volume, cognition, and gait

Eric E Smith, Martin O'Donnell, Gilles Dagenais, Scott A Lear, Andreas Wielgosz, Mukul Sharma, Paul Poirier, Grant Stotts, Sandra E Black, Stephen Strother, Michael D Noseworthy, Oscar Benavente, Jayesh Modi, Mayank Goyal, Saima Batool, Karla Sanchez, Vanessa Hill, Cheryl R McCreary, Richard Frayne, Shofiqul Islam, Jane DeJesus, Sumathy Rangarajan, Koon Teo, Salim Yusuf, PURE Investigators, Eric E Smith, Martin O'Donnell, Gilles Dagenais, Scott A Lear, Andreas Wielgosz, Mukul Sharma, Paul Poirier, Grant Stotts, Sandra E Black, Stephen Strother, Michael D Noseworthy, Oscar Benavente, Jayesh Modi, Mayank Goyal, Saima Batool, Karla Sanchez, Vanessa Hill, Cheryl R McCreary, Richard Frayne, Shofiqul Islam, Jane DeJesus, Sumathy Rangarajan, Koon Teo, Salim Yusuf, PURE Investigators

Abstract

Objective: Decline in cognitive function begins by the 40s, and may be related to future dementia risk. We used data from a community-representative study to determine whether there are age-related differences in simple cognitive and gait tests by the 40s, and whether these differences were associated with covert cerebrovascular disease on magnetic resonance imaging (MRI).

Methods: Between 2010 and 2012, 803 participants aged 40 to 75 years in the Prospective Urban Rural Epidemiological (PURE) study, recruited from prespecified postal code regions centered on 4 Canadian cities, underwent brain MRI and simple tests of cognition and gait as part of a substudy (PURE-MIND).

Results: Mean age was 58 ± 8 years. Linear decreases in performance on the Montreal Cognitive Assessment, Digit Symbol Substitution Test (DSST), and Timed Up and Go test of gait were seen with each age decade from the 40s to the 70s. Silent brain infarcts were observed in 3% of 40- to 49-year-olds, with increasing prevalence up to 18.9% in 70-year-olds. Silent brain infarcts were associated with slower timed gait and lower volume of supratentorial white matter. Higher volume of supratentorial MRI white matter hyperintensity was associated with slower timed gait and worse performance on DSST, and lower volumes of the supratentorial cortex and white matter, and cerebellum.

Interpretation: Covert cerebrovascular disease and its consequences on cognitive and gait performance and brain atrophy are manifest in some clinically asymptomatic persons as early as the 5th decade of life.

© 2015 The Authors Annals of Neurology published by Wiley Periodicals, Inc. on behalf of American Neurological Association. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Figures

FIGURE 1
FIGURE 1
Distribution of magnetic resonance imaging white matter hyperintensity (WMH) by age decade. Red-to-yellow color indicates the probability of WMH at that location.
FIGURE 2
FIGURE 2
Brain regions where age was associated with cortical thickness. Advanced age was associated with decreased cortical thickness in many brain regions, most significantly in the superior frontal gyrus, inferior frontal gyrus, posterior superior and middle temporal gyri, precuneus, and supramarginal and inferior parietal cortex. Primary motor and sensory areas and the medial temporal lobe were less strongly associated with age, and there were small regions of anterior cingulate cortex and medial orbitofrontal cortex where advanced age was associated with increased cortical thickness. The color bar indicates the t value for the association; blue colors indicate regions of negative association (ie, where cortical thickness was lower in older subjects) and red–yellow colors indicate regions of positive association (ie, where cortical thickness was higher in older subjects).The false discovery rate method with alpha = 0.05 was used to correct for multiple comparisons.
FIGURE 3
FIGURE 3
Brain regions where white matter hyperintensity (WMH) is associated with cortical thickness. Higher WMH volume is associated with decreased cortical thickness in the superior parieto-occipital cortex and in the lingual gyrus of the left hemisphere only. The false discovery rate method was used to correct for multiple comparisons, with alpha set at 0.01 to account for comparisons with the 3 manifestations of small vessel disease analyzed (WMH, silent brain infarcts, and microbleeds). Average cortical thickness was not associated with silent brain infarcts or microbleeds.

References

    1. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689–701.
    1. Vermeer SE, Longstreth WT, Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol. 2007;6:611–619.
    1. LADIS Study Group. 2001–2011: a decade of the LADIS (Leukoaraiosis And DISability) Study: what have we learned about white matter changes and small-vessel disease? Cerebrovasc Dis. 2011;32:577–588.
    1. Debette S, Beiser A, DeCarli C, et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke. 2010;41:600–606.
    1. Vermeer SE, Den Heijer T, Koudstaal PJ, et al. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke. 2003;34:392–396.
    1. Singh-Manoux A, Kivimaki M, Glymour MM, et al. Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ. 2012;344:d7622.
    1. Yusuf S, Islam S, Chow CK, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet. 2011;378:1231–1243.
    1. Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37:2220–2241.
    1. Kaplan E, Fein D, Morris R, Delis D. The WAIS-R as a neuropsychological instrument. San Antonio, TX: Psychological Corporation; 1991.
    1. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–699.
    1. Bohannon RW. Comfortable and maximum walking speed of adults aged 20–79 years: reference values and determinants. Age Ageing. 1997;26:15–19.
    1. Gunter JL, Bernstein MA, Borowski BJ, et al. Measurement of MRI scanner performance with the ADNI phantom. Med Phys. 2009;36:2193–2205.
    1. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822–838.
    1. Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341–355.
    1. Desikan RS, Segonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31:968–980.
    1. Hoyer WJ, Stawski RS, Wasylyshyn C, Verhaeghen P. Adult age and digit symbol substitution performance: a meta-analysis. Psychol Aging. 2004;19:211–214.
    1. Kenny RA, Coen RF, Frewen J, et al. Normative values of cognitive and physical function in older adults: findings from the Irish Longitudinal Study on Ageing. J Am Geriatr Soc. 2013;61(suppl 2):S279–S290.
    1. Pendlebury ST, Cuthbertson FC, Welch SJ, et al. Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke. 2010;41:1290–1293.
    1. Rosano C, Newman AB, Katz R, et al. Association between lower digit symbol substitution test score and slower gait and greater risk of mortality and of developing incident disability in well-functioning older adults. J Am Geriatr Soc. 2008;56:1618–1625.
    1. Bohannon RW. Reference values for the timed up and go test: a descriptive meta-analysis. J Geriatr Phys Ther. 2006;29:64–68.
    1. Kohara K, Fujisawa M, Ando F, et al. MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: the NILS-LSA Study. Stroke. 2003;34:1130–1135.
    1. DeCarli C, Massaro J, Harvey D, et al. Measures of brain morphology and infarction in the Framingham heart study: establishing what is normal. Neurobiol Aging. 2005;26:491–510.
    1. Schmidt R, Ropele S, Enzinger C, et al. White matter lesion progression, brain atrophy, and cognitive decline: the Austrian Stroke Prevention study. Ann Neurol. 2005;58:610–616.
    1. Ikram MA, Vernooij MW, Vrooman HA, et al. Brain tissue volumes and small vessel disease in relation to the risk of mortality. Neurobiol Aging. 2009;30:450–456.
    1. Hoogendam YY, van der Geest JN, van der Lijn F, et al. Determinants of cerebellar and cerebral volume in the general elderly population. Neurobiol Aging. 2012;33:2774–2781.
    1. van Velsen EF, Vernooij MW, Vrooman HA, et al. Brain cortical thickness in the general elderly population: the Rotterdam Scan Study. Neurosci Lett. 2013;550:189–194.
    1. Maillard P, Seshadri S, Beiser A, et al. Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study. Lancet Neurol. 2012;11:1039–1047.
    1. Mortamet B, Bernstein MA, Jack CR, Jr, et al. Automatic quality assessment in structural brain magnetic resonance imaging. Magn Reson Med. 2009;62:365–372.
    1. Han X, Jovicich J, Salat D, et al. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage. 2006;32:180–194.
    1. Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage. 2002;15:870–878.

Source: PubMed

3
Sottoscrivi